Skip to content
Review Open access

BRAIN METASTASES AT THE INTERFACE OF CLINICAL ONCOLOGY AND NEURORADIOLOGY: A NARRATIVE REVIEW OF DETECTION, RESPONSE ASSESSMENT AND THE POST-TREATMENT BRAIN

Sep 2026 · Revista CPAQV. Centro de Pesquisas Avançadas em Qualidade de Vida · 0 citations

Abstract

 Background. Brain metastases are the most frequent intracranial tumours in adults, and their management has been transformed twice over in a decade: first by the replacement of whole-brain radiotherapy with focal radiation for limited intracranial disease, and then by the arrival of systemic agents with genuine intracranial activity. Both shifts moved decisive weight onto imaging, which now determines eligibility, defines the endpoint, and adjudicates whether an enlarging lesion is tumour or treatment effect. Objective. To review, in narrative form, the contribution of neuroradiology to the contemporary management of brain metastases from solid tumours, spanning detection, differential diagnosis, response assessment, the post-treatment brain, leptomeningeal disease and artificial intelligence (AI). Methods. PubMed was searched for Englishlanguage articles indexed up to September 2026, combining terms for brain and leptomeningeal metastasis, imaging technique, radiotherapy modality, systemic agents with central nervous system (CNS) activity, response criteria and machine learning. Priority was given to society guidelines, randomised trials with intracranial endpoints, diagnostic test-accuracy meta-analyses and multicentre validation studies; selection was purposive rather than systematic. Findings. Detection is protocol-determined rather than reader-determined: black-blood three-dimensional sequences raise sensitivity for lesions under 5 mm from 72.5% to 98.0% against a combined reference, and deep-learning assistance improves count agreement while shortening reading time. Differential diagnosis of a solitary lesion rests largely on the peritumoral compartment. In the post-treatment brain, perfusion and spectroscopy separate recurrence from radiation necrosis only at the group level, whereas amino acid positron emission tomography (PET) reaches 88% accuracy in single-centre series and 89% when combined with contrast-enhanced MRI radiomics. Randomised evidence has redefined what imaging must measure: focal radiation preserves cognition without an overall survival cost, and modern systemic agents produce intracranial responses of 53-82%, so intracranial progression-free survival has become a primary endpoint that only reproducible neuroradiology can support. RANO-BM standardised that measurement but remains bidimensional, size-thresholded and blind to the non-enhancing compartment. Conclusion. The imaging questions posed by brain metastases are now mostly oncological questions. Their answers require standardised acquisition, explicit criteria, disciplined use of a small number of advanced techniques, and automation that is validated where it will be deployed. 

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.